PharMerica Reports First Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Needham Starts NeoVolta (NEOV) at Buy
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- SanDisk stock target lifted by Citi on continued demand strength
UBS Raises Price Target on Pharmerica (PMC) to $27; Remains Neutral
May 9, 2016 8:53 AM EDTUBS reiterated a Neutral rating on PharMerica (NYSE: PMC), and raised the price target to $27.00 (from $22.00), following the company's 1Q earnings report. On its conference call management provided 2Q16 guidance of $500-510 mln in revenues, $30.9-$31.9 mln of adjusted EBITDA, and EPS of $0.46-$0.48.... More
Pharmerica (PMC) Tops Q1 EPS by 2c
May 6, 2016 8:17 AM EDTPharmerica (NYSE: PMC) reported Q1 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $524.5 million versus the consensus estimate of $509.45 million.
Pharmerica reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Pharmerica (PMC) click here.
... More